R5 is a contract pharmaceutical sciences company based in Nottingham, England. Licensed by MHRA for the manufacture and testing of IMPs (Investigational Medical Products - products used in human testing of new medicines). Their business is the development of new medicines for Phase 1 and 2 (the early phases of clinical trials).
They have the capability, staff and in house facilities to develop most dosage forms including tablets, liquids, topicals and sterile products. Customers include pharma and biotech from EU, Japan, Korea, USA and Australia.
The company is 3.5 years old with approx 50 staff, and is managed by a small team of directors who established the company in 2006.